IndraLab

Statements


NCT503 binds EIF3F. 1 / 1
| 1

reach
"These data indicate that EIF3F is a transcriptional target of the Wnt signaling pathway via β‐catenin/TCF4 binding to the EIF3F promoter.2.7 Combination Treatment of NCT503 and LGK-974 Mitigated Tumor Growth in eIF3f High Human PDX CRC Models with Better Efficacy through Hindering Wnt-eIF3f-PHGDH Signaling Axis."